IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Caligan Partners LPActivist

Portfolio Profile

CIK: 0001727492 | NEW YORK, NY

Investment Profile

Style

Aggressive Growth

Turnover

Medium

Orientation

Concentrated trader
$2.1B
AUM
25
Positions
82.94%
Top 10 Conc.
100%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Liquidia Corporation(LQDA)8,118,892$647.3M30.45%
2Revolution Medicines Inc(RVMD)1,961,795$367.4M17.28%
3Abivax SA(ABVX)1,557,924$207.6M9.77%
4Vaxcyte Inc(PCVX)2,188,636$127.2M5.99%
5Exelixis Inc

Sector Allocation

Latest filing, equity positions only

Healthcare100% · $2.1B

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare99.93%100%+0.07%
Unclassified0.07%0%-0.07%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

Cap SizePrev %Curr %

AUM History

$217.8M | 13 pos.
$296.5M | 11 pos.
$378.3M | 12 pos.
$428.0M | 13 pos.
$315.5M | 12 pos.
$394.9M | 14 pos.
(EXEL)
1,553,262
$84.5M
3.98%
6Tango Therapeutics Inc(TNGX)2,500,103$78.2M3.68%
7Avalo Therapeutics Inc(AVTX)3,163,866$58.5M2.75%
8Xenon Pharmaceuticals Inc(XENE)889,944$53.7M2.53%
9Adma Biologics Inc(ADMA)5,725,007$47.9M2.25%
10LB Pharmaceuticals Inc(LBRX)1,438,070$46.7M2.20%
Change
Mid Cap61.87%59.25%-2.62%
Large Cap16.08%21.8%+5.72%
Small Cap16%10.78%-5.22%
Micro Cap5.98%8.17%+2.19%
Unclassified0.07%0%-0.07%
$479.2M | 16 pos.
$520.2M | 17 pos.
$763.5M | 18 pos.
$1.2B | 24 pos.
$1.5B | 28 pos.
$2.1B | 28 pos.
Q3
23
Q4
23
Q1
24
Q2
24
Q3
24
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

5
New
5
Closed
11
Increased
3
Decreased
9
Unchanged